
Akticef S 1000mg/500mg Injection
Marketer
Aktimas Bio Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Akticef S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance; adhere to all scheduled doses. Complete the prescribed course, regardless of symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before use. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the drug's impact.
Primary Ingredients of Akticef S 1000mg/500mg Injection
No information provided. Therefore, no text can be rewritten.
Uses of Akticef S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Akticef S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Akticef S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Akticef S 1000mg/500mg Injection:
Administering this medication requires the assistance of your physician or registered nurse; self-medication is strictly prohibited.
How Akticef S 1000mg/500mg Injection works:
The injectable formulation Akticef S (1000mg Ceftriaxone/500mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, by countering bacterial resistance enzymes, optimizes Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Akticef S 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Akticef S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Akticef S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Akticef S 1000mg/500mg Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Akticef S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Akticef S (1000mg/500mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Akticef S (1000mg/500mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Akticef S 1000mg/500mg Injection :
Omitting a scheduled dose of Akticef S 1000mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Akticef S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
